NICE Consults On Revised First Draft Guidance On The Use Of Drugs To Treat Alzheimer''s Disease (including A Review Of Existing Guidance No. 19), UK
Tue, 24 Jan 2006 06:00 PM EST
... The National Institute for Health and Clinical Excellence (NICE) is consulting on the revised draft of its review of donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer''s disease. The document has been published on the NICE website for a three week public consultation period which ends on 13 February 2006... click link for more info. ...
Related Topics
- Counseling And Guidance
- CMP
- Alzheimer disease, type 2
- Alzheimer disease
- Crohn's Disease
- CA 19-9
- Alzheimer's Disease
- Respiratory Diseases
- Congenital Heart Disease
- Disease-modifying anti-rheumatoid drugs
- Vasculitis including Temporal Arteritis
- Coma, including Persistent Vegetative State
- Diseases & Conditions
- Alzheimer's
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases

Not Signed In -


